Companies

Entelos Inc

Overview

US-based Entelos Inc develops predictive biosimulation models, which can be used instead of animals to test drugs. Clinical testing can be done from inception to the point where there is a product. Pfizer is a shareholder and other users of the models include Lilly, Johnson & Johnson and Unilever. It can be used for drugs and consumer products. It is estimated that Entelos' technology could cut the cost of developing a drug by $125m. Entelos joined Aim on 12 April 2006, when it raised £11.4m at 82.75p.

Sector: Health

News blog

• Entelos Inc Posted: 01/06/2009
• Entelos Inc Posted: 04/02/2009
• Entelos Inc Posted: 21/11/2008
• Entelos Inc Posted: 10/10/2008
• Entelos Inc Posted: 28/09/2008

Browse by sector

All companies

• Aim advisers
• Aim Awards
• Aim investor relations
• Cleantech
• Construction
• Consumer
• Electricals
• Financial
• Food
• Health
• Industrial
• Leisure
• Media
• Mobile
• Property
• QUOTED MICRO
• Resources
• Retail
• Security
• Services
• Technology
• Telecoms
• Training
• Transport

• 2.4mNumber of messages posted on SocialGo networks
  
• $38mCost savings generated by ideas from WalMart staff over a two month period